| Name | selenoprotein W |
| Description | This gene encodes a selenoprotein containing a selenocysteine (Sec) residue, which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element that is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. This protein is highly expressed in skeletal muscle, heart and brain. It belongs to the SelWTH family, which possesses a thioredoxin-like fold and a conserved CxxU (C is cysteine, U is Sec) motif, suggesting a redox function for this gene. Studies in mouse show that this selenoprotein is involved in muscle growth and differentiation, and in the protection of neurons from oxidative stress during neuronal development. A retroprocessed pseudogene of this locus has been identified on chromosome 1. [provided by RefSeq, Aug 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSELENOW, also known as selenoprotein W (SEPW1), is a small, thioredoxinâlike selenoenzyme that is widely expressed throughout the body. Although initial molecular profiling studies in breast cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "and multiple myeloma endothelial cells"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "focused on complex regulatory networks, detailed gene mapping revealed that the SEPW1 gene is distributed over approximately 6.3 kb with ubiquitous expressionâshowing particularly high levels in skeletal muscle and heart."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, studies using diverse selenium (Se) supplementation or depletion models demonstrated that SELENOW expression is exquisitely sensitive to Se levels. In colonic mucosa and human intestinal cells, for example, Se-depletion leads to dramatic falls in its mRNA levels"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", while in neuronal cells modest changes in Se supply modulate its expression"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", and similar findings were observed when various selenium compounds were tested."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFunctional investigations in epithelial cells derived from breast and prostate tissues have underscored a central role for SELENOW in cell cycle progression. Multiple studies have shown that down-regulation or silencing of SELENOW provokes a transient arrest at the G1/S transition, an effect correlated with increases in p53 protein levels and its target p21 as well as reduced ubiquitination of p53"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " In fact, SELENOW mRNA peaks in G1-phase and declines after the G1/S transition, while its depletion interferes with EGF-induced signaling by enhancing EGFR ubiquitination and accelerating receptor degradation"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " Furthermore, studies in prostate adenocarcinoma cells confirm that treatment with sodium selenite alters SELENOW mRNA expression, reinforcing its potential role in modulating tumor cell proliferation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its functions in cell cycle regulation, SELENOW plays a key role in redox signaling and the modulation of stress responses. Its conserved selenocysteine residue within a CXXU motif is critical for interactions with regulatory proteins such as 14-3-3, where oxidative conditions enhance binding."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Beyond redox control, SELENOW interacts with partners including PKM2 and FAM96B to influence metabolic reprogramming, which in hepatocytes contributes to mitochondrial apoptosis, increased reactive oxygen species, and activation of inflammasome pathways in conditions such as non-alcoholic fatty liver disease"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " Moreover, in the context of bone health, forced overexpression of SELENOW in multiple myeloma has been linked to excessive osteoclast differentiation and bone resorption."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Liping Tan, Dongmei Mai, Bailin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIWI-interacting RNA-36712 restrains breast cancer progression and chemoresistance by interaction with SEPW1 pseudogene SEPW1P RNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-019-0940-3"}], "href": "https://doi.org/10.1186/s12943-019-0940-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30636640"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30636640"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Roberto Ria, Katia Todoerti, Simona Berardi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-09-0040"}], "href": "https://doi.org/10.1158/1078-0432.CCR-09-0040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19690192"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19690192"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "James Bellingham, Kevin Gregory-Evans, Margaret F Fox, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene structure and tissue expression of human selenoprotein W, SEPW1, and identification of a retroprocessed pseudogene, SEPW1P."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0167-4781(03)00078-2"}], "href": "https://doi.org/10.1016/s0167-4781(03"}, {"type": "t", "text": "00078-2) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12818432"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12818432"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Vasileios Pagmantidis, Giovanna Bermano, Stephane Villette, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of Se-depletion on glutathione peroxidase and selenoprotein W gene expression in the colon."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2004.12.042"}], "href": "https://doi.org/10.1016/j.febslet.2004.12.042"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15670848"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15670848"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Youn-Jung Kim, Young-Gyu Chai, Jae-Chun Ryu "}, {"type": "b", "children": [{"type": "t", "text": "Selenoprotein W as molecular target of methylmercury in human neuronal cells is down-regulated by GSH depletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2005.03.080"}], "href": "https://doi.org/10.1016/j.bbrc.2005.03.080"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15823556"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15823556"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Anna Patricia Kipp, Janna Frombach, Stefanie Deubel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Selenoprotein W as biomarker for the efficacy of selenium compounds to act as source for selenoprotein biosynthesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Methods Enzymol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/B978-0-12-405882-8.00005-2"}], "href": "https://doi.org/10.1016/B978-0-12-405882-8.00005-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23830627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23830627"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Wayne Chris Hawkes, Zeynep Alkan "}, {"type": "b", "children": [{"type": "t", "text": "Delayed cell cycle progression from SEPW1 depletion is p53- and p21-dependent in MCF-7 breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2011.08.032"}], "href": "https://doi.org/10.1016/j.bbrc.2011.08.032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21875573"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21875573"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wayne Chris Hawkes, Thomas T Y Wang, Zeynep Alkan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Selenoprotein W modulates control of cell cycle entry."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Trace Elem Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12011-009-8367-0"}], "href": "https://doi.org/10.1007/s12011-009-8367-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19387567"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19387567"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Wayne Chris Hawkes, Zeynep Alkan "}, {"type": "b", "children": [{"type": "t", "text": "Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.346593"}], "href": "https://doi.org/10.1074/jbc.M112.346593"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22730327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22730327"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Wayne Chris Hawkes, Ignat Printsev, Zeynep Alkan "}, {"type": "b", "children": [{"type": "t", "text": "Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.23328"}], "href": "https://doi.org/10.1002/jcb.23328"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21866568"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21866568"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Zeynep Alkan, Frank L Duong, Wayne C Hawkes "}, {"type": "b", "children": [{"type": "t", "text": "Selenoprotein W controls epidermal growth factor receptor surface expression, activation and degradation via receptor ubiquitination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2015.02.016"}], "href": "https://doi.org/10.1016/j.bbamcr.2015.02.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25721765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25721765"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "E G Varlamova, M V Goltyaev, J P Kuznetsova "}, {"type": "b", "children": [{"type": "t", "text": "[Effect of Sodium Selenite on Gene Expression of SELF, SELW, and TGR Selenoproteins in Adenocarcinoma Cells of the Human Prostate]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol (Mosk) (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7868/S0026898418030151"}], "href": "https://doi.org/10.7868/S0026898418030151"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29989584"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29989584"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yeong Ha Jeon, Kwan Young Ko, Jea Hwang Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a redox-modulatory interaction between selenoprotein W and 14-3-3 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2015.10.006"}], "href": "https://doi.org/10.1016/j.bbamcr.2015.10.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26474786"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26474786"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Zhiruo Miao, Wei Wang, Zhiying Miao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of Selenoprotein W in participating in the progression of non-alcoholic fatty liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Redox Biol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.redox.2024.103114"}], "href": "https://doi.org/10.1016/j.redox.2024.103114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38460355"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38460355"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ping Chen, Chao Wang, Qing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of FAM96B as a novel selenoprotein W binding partner in the brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.02.139"}], "href": "https://doi.org/10.1016/j.bbrc.2019.02.139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30876693"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30876693"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Hyunsoo Kim, Jiin Oh, Min Kyoung Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Selenoprotein W engages in overactive osteoclast differentiation in multiple myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-024-09517-2"}], "href": "https://doi.org/10.1007/s11033-024-09517-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38683225"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38683225"}]}]}]}
|
| NCBI Gene ID | 6415 |
| API | |
| Download Associations | |
| Predicted Functions |
 |
| Co-expressed Genes |
|
| Expression in Tissues and Cell Lines |
|
SELENOW has 4,151 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 35 datasets.
Click the + buttons to view associations for SELENOW from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SELENOW gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SELENOW gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SELENOW gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SELENOW gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of SELENOW gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SELENOW protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SELENOW protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SELENOW protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SELENOW gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SELENOW gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SELENOW gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SELENOW gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SELENOW gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SELENOW gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SELENOW gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SELENOW gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate SELENOW protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SELENOW gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SELENOW gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SELENOW gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SELENOW gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SELENOW protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SELENOW protein from the Wikipathways PFOCR 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SELENOW gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SELENOW gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SELENOW gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of SELENOW gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SELENOW gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SELENOW gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SELENOW gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SELENOW gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SELENOW protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SELENOW protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SELENOW protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SELENOW protein from the WikiPathways Pathways 2024 dataset. | |
